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A B S T R A C T   
Hippocampal damage and associated cognitive deficits are frequently observed in neuroimmunological disor-
ders, but comparative analyses to identify shared hippocampal damage patterns are missing. Here, we adopted a 
transdiagnostic analytical approach and investigated hippocampal shape deformations and associated cognitive 
deficits in four neuroimmunological diseases. 
We studied 120 patients (n = 30 in each group), including patients with multiple sclerosis (MS), neuromyelitis 
optica spectrum disorder (NMOSD), anti-NMDAR and anti-LGI1 encephalitis. A control group was matched to 
each patient sample from a pool of 79 healthy participants. We performed an MRI-based vertex-wise hippo-
campal shape analysis, extracted hippocampal volume estimates and scalar projection values as a measure of 
surface displacement. Cognitive testing included assessment of verbal memory and semantic fluency 
performance. 
Our cross-sectional analyses revealed characteristic patterns of bilateral inward deformations covering up to 
32% of the hippocampal surface in MS, anti-NMDAR encephalitis, and anti-LGI1 encephalitis, whereas NMOSD 
patients showed no deformations compared to controls. Significant inversions were noted mainly on the hip-
pocampal head, were accompanied by volume loss, and correlated with semantic fluency scores and verbal 
episodic memory in autoimmune encephalitis and MS. A deformation overlap analysis across disorders revealed a 
convergence zone on the left anterior hippocampus that corresponds to the CA1 subfield. 
This convergence zone indicates a shared downstream substrate of immune-mediated damage that appears to 
be particularly vulnerable to neuroinflammatory processes. Our transdiagnostic morphological view sheds light 
on mutual pathophysiologic pathways of cognitive deficits in neuroimmunological diseases and stimulates 
further research into the mechanisms of increased susceptibility of the hippocampus to autoimmunity.   
1. Introduction 
The hippocampus is a frequent target in many neuroimmunological 
diseases despite their distinct pathophysiological mechanisms. 
Accumulating evidence suggests a selective vulnerability of the hippo-
campus, and particularly its subfield CA1, to inflammatory processes 
(Bartsch and Wulff, 2015). Consequently, largely overlapping cognitive 
deficits are observed in neuroimmunological disorders, including 
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impairments of episodic memory, spatial navigation and affective pro-
cessing (Finke et al., 2012, 2017; Gold et al., 2014; Oertel et al., 2019). 
Here, we directly compared hippocampal damage and associated 
cognitive deficits in four distinct neuroimmunological disorders using 
the same imaging analysis protocol in order to explore the hypothesis of 
selective vulnerability and to identify shared hippocampal damage 
patterns. 
Previous imaging studies have identified characteristic hippocampal 
damage patterns leading to cognitive deficits in neuroimmunological 
disorders. In multiple sclerosis, for example, MRI analyses revealed a 
hippocampal volume reduction associated with impaired verbal and 
visuospatial memory performance (Sicotte et al., 2008). Anti-NMDA 
receptor (NMDAR) encephalitis is a recently discovered autoimmune 
encephalitis with autoantibodies targeting the NR1 subunit of the 
NMDA receptor (Dalmau and Graus et al., 2018). The hippocampus 
contains the highest density of NMDARs and, consequently, volume loss, 
impaired microstructural integrity and disrupted functional connectiv-
ity of the hippocampus are characteristic imaging findings that correlate 
with the severity of memory impairment (Finke et al., 2016a). Auto-
immune encephalitis with LGI1 antibodies manifests as limbic enceph-
alitis with bilateral hippocampal inflammation detectable in 60–85% of 
patients (Finke et al., 2017; van Sonderen et al., 2016; Thompson et al., 
2018). At later disease stages, almost all patients develop atrophy and 
impaired microstructural integrity of the hippocampus that relates to 
marked memory deficits (Finke et al., 2017; Kotsenas et al., 2014). In 
contrast, the majority of imaging studies observed no volume reduction 
or microstructural changes of the hippocampus in patients with neuro-
myelitis optica spectrum disorder (NMOSD) (Calabrese et al., 2012; 
Finke et al., 2016b). 
However, to date, there have been no comparative approaches that 
characterize hippocampal damage patterns across different neuro-
immunological diseases. Considering the shared cognitive symptoms, 
such transdiagnostic approaches can identify common downstream 
mechanisms that give rise to mutual clinical presentations and may 
therefore help to improve the pathophysiological understanding of 
neuropsychiatric symptoms (Husain, 2017). In addition, volumetric 
analyses only assess global hippocampal changes, while shape analyses 
can identify the exact spatial distribution of atrophy by providing 
discrete information about the location of pathological changes on a 
brain structure’s surface. Indeed, shape deformations were shown to 
provide a sensitive marker of hippocampal pathology that can track 
disease progression in patients with memory disorders (Csernansky 
et al., 2005; Gerardin et al., 2009; Postma et al., 2020). 
We therefore performed a comprehensive vertex-based shape anal-
ysis of the hippocampus in patients with four different neuro-
immunological disorders, i.e. multiple sclerosis (MS), neuromyelitis 
optica spectrum disorder (NMOSD), anti-NMDA receptor (NMDAR) 
encephalitis and anti-LGI1 encephalitis. The aims of this study are to (1) 
describe the spatial patterns of pathological changes on the hippocampal 
surface, (2) provide comparative data and identify shared trans-
diagnostic damage patterns for these disorders, (3) and complement 
previous volumetric analyses by morphological assessments. 
2. Materials & methods 
2.1. Participants 
We included one hundred twenty patients with four different neu-
roimmunological disorders, i.e. patients with NMDAR encephalitis (n =
30), LGI1 encephalitis (n = 30), relapsing remitting multiple sclerosis 
(RRMS; n = 30) and aquaporin-4 antibody positive NMOSD (n = 30). All 
patients were recruited from the outpatient clinics of the NeuroCure 
Clinical Research Center and the Department of Neurology of Charité - 
Universitätsmedizin Berlin between 2012 and 2017, except for eleven 
LGI1 encephalitis patients that were recruited at the University Hospital 
Schleswig-Holstein in Kiel. NMDAR encephalitis and LGI1 encephalitis 
patients were studied after the acute stage of the disease and were 
diagnosed based on the proposed criteria of characteristic clinical pre-
sentation, cerebrospinal fluid findings, neuroimaging changes and 
autoantibody detection (IgG NMDAR antibodies in CSF and IgG LGI1 
antibodies in CSF or serum) (Graus et al., 2016). Patients with multiple 
sclerosis fulfilled the 2017 revised McDonald criteria and were on stable 
immunomodulatory therapy for at least three months, with no acute 
relapse for at least three months prior to enrolment and without corti-
costeroid therapy in the last 30 days. All NMOSD patients fulfilled the 
2015 international consensus diagnostic criteria for NMOSD and were 
tested positive for AQP4 antibodies; no patient was MOG-antibody 
seropositive. Demographic and clinical descriptions of the study 
groups are provided in Table 1. Lesion segmentations for the charac-
terization of MS and NMOSD patients was performed on 3D FLAIR im-
ages using the semiautomatic Lesion Segmentation Toolbox (LST) 
(Schmidt et al., 2012) for SPM. We created an individual control group 
for each clinical sample by performing a 1:1 matching (regarding age 
and sex) between patients and healthy control participants drawn from a 
pool of seventy-nine healthy volunteers. 
All participants gave informed written consent. The study was 
approved by the Ethics Committee of Charité – Universitätsmedizin 
Berlin and conducted in accordance with the Declaration of Helsinki. 
2.2. MRI data acquisition 
A 3-dimensional, high-resolution T1-weighted sequence (Magneti-
zation Prepared Rapid Acquisition Gradient Echo; MPRAGE, voxel size 
1 × 1 × 1 mm3) and a 3D FLAIR/T2 sequence (Fluid-Attenuated 
Inversion Recovery; voxel size 1 × 1 × 1 mm3) were acquired for each 
participant on a 3T Siemens Tim Trio scanner (Siemens, Erlangen, 
Germany) at the Berlin Center for Advanced Neuroimaging. Eleven LGI1 
encephalitis patients and matched controls were examined at the Uni-
versity Hospital Schleswig-Holstein in Kiel on a 3T Philips Achieva 
scanner using the same sequence. Study site was accounted for as a 
covariate in the general linear model. 
2.3. Surface-based analyses and statistics 
The segmentation of the left and right hippocampi was performed 
using FMRIB’s Integrated Registration and Segmentation Tool (FIRST) 
as implemented in FSL (www.fmrib.ox.ac.uk). As detailed previously 
(Patenaude et al., 2011), the FIRST algorithm automatically segments 
the hippocampus based on shape models and voxel intensities. A 
deformable mesh model is used to create a surface mesh for each hip-
pocampus. Each mesh is composed of a set of triangles with a fixed 
number of vertices, i.e. apices of adjoining triangles, for each structure. 
This allows for comparisons of corresponding vertices between groups. 
The segmentations were visually examined to confirm the accuracy of 
the results. For between-group comparisons, we performed separate T- 
tests for the left and right hippocampi using FSL Randomise with 
threshold-free cluster enhancement (TFCE). Contrasts were designed to 
test for both atrophy and growth to allow for the detection of changes in 
both directions. Vertex-wise T-statistics were corrected for multiple 
comparisons and the presented maps survived TFCE with a q < 0.05 FDR 
correction. 
Next, we extracted summary statistics for the scalar projection values 
and volumes using the FSL-Utils toolbox. During the analysis, the surface 
locations of each individual’s hippocampus are projected onto the 
cohort average surface, which reflects the mean surface position across 
patients and control participants. This allows a quantification of the 
distance between an individual’s hippocampal surface and the cohort 
average hippocampal surface at all vertices. Scalar values represent this 
perpendicular distance of a vertex. 
As a reference, we collected volume estimates of the hippocampi, 
which were corrected for intracranial volume (ICV) using the following 
formula: volumeadjusted = volumeraw − β (ICVraw − ICVmean); with β 
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referring to the slope of the linear regression of a participant’s ICV on 
their raw hippocampal volume. ICV measures were determined using 
FSL Sienax (Smith et al., 2002). Descriptive statistics are presented with 
mean and standard error. Group-based analyses between patients and 
controls were performed using multivariate analyses of variances and 
receiver operating characteristics (ROC) for continuous data of the left 
and right hippocampus. P-values < .05 were considered significant. The 
Shapiro-Wilk test was used to assess the normality of the data. 
2.4. Between-group similarity analysis 
Finally, the pattern similarity of affected hippocampal surface areas 
was compared between diseases. To this end, the results of the 
normalized shape analysis were binarized for each disease group, with 1 
coding a significantly affected vertex and 0 coding a non-affected sur-
face vertex. We determined the contingency coefficient phi (Φ) for the 
extracted matrices using the Chi-Square test for categorical data. Φ 
constitutes a measure of correlation between two binary variables and 
allows a quantification of pattern similarity between diseases. 
Figures showing surface renderings were created using SurfIce (https 
://www.nitrc.org/projects/surfice/) and FSL FIRST3Dview. 
2.5. Association with cognitive performance 
Cognitive performance of patients was assessed for the purpose of 
correlational analyses. We assessed verbal fluency using a 1-minute se-
mantic fluency task (category ‘animals’; Regensburg Word Fluency Test 
(NMDA/LGI1 patients); and the identical Word List Generation subtest 
of the Brief Repeatable Battery of Neuropsychological Tests (BRB-N; 
RRMS/NMOSD patients). Verbal learning and memory were tested using 
two equivalent multiple-trial list-learning paradigms (German version of 
the Rey Auditory Verbal Learning Test (RAVLT; NMDA/LGI1 patients); 
Selective Reminding Test (SRT; RRMS/NMOSD patients). Depressive 
symptoms were assessed in all participants using the Beck Depression 
Inventory (BDI-II). Correlational analyses were performed using Pear-
son/Spearman correlation coefficients in IBM SPSS Statistics 22. 
Table 1 
Sample characteristics. a Disease duration is calculated as the time span between symptom onset and time of MRI. b Disease severity was assessed using the modified 
Rankin Scale (mRS) and the Expanded Disability Status Scale (EDSS) at the study date. c Scoring: 0–8 no depression, 9–13 minimal depression, 14–19 mild depression, 
20–28 moderate depression, 29–63 severe depression. (BDI-II: Beck Depression Inventory – Revision; RAVLT: Rey Auditory Verbal Learning Test; SRT-LTS: Selective 
Reminding Test – long-term storage; RWT: Regensburg Word Fluency Test; WLG: Word List Generation Test).   
NMDA LGI1 RRMS NMOSD 
Sex     
Patients 26 f, 4 m 9 f, 21 m 18 f, 12 m 27 f, 3 m 
Controls 26 f, 4 m 9 f, 21 m 18 f, 12 m 27 f, 3 m 
Age     
Patients (mean 
(±SD)) 
















21.0 months 23.3 months 163.5 months 47.0 months 





mRS mRS EDSS EDSS 
2 (0–3) 2 (0–4) 2 (1–5) 4 (0–6.5) 
Clinical MRI     
T2 lesion count 
Median 
(range) 
– – 34 (3–126) 9 (0–68) 
T2 lesion 
volume     
Mean (SD) – – 9.3 ± 7.4 ml 2.1 ± 2.3 ml 
Acute phase 
MRI     
(No. of affected 
patients) 
13/30 patients with abnormal MRI: Unilateral T2/FLAIR 
hyperintensities (temporal (5), basal ganglia (1), thalamus 
(1)), T2-hyperintense white matter lesions 
(periventricular (6), frontal/opercular (4)), mild global 
atrophy (1) 
25/30 patients with abnormal MRI: Unilateral T2/FLAIR 
hyperintensities (left hippocampus (4), right hippocampus 
(5), right insula (1)), Bilateral T2/FLAIR hyperintensities 
(hippocampus (11), amygdala (5)), subcortical 
arteriosclerotic encephalopathy (3), periventricular 




22/30 patients (complex-focal (2), generalized tonic- 
clonic (6), status epilepticus (1), unknown type (13)) 
FBDS: 16/30 patients – – 
Seizures: 13/30 patients (pilomotor (4), complex-focal (5), 
generalized tonic-clonic (4)) 
Therapy delay 37 (1–1,096) days 49 (7–400) days – – 
Median (range) 
Memory score RAVLT sum score RAVLT sum score SRT-LTS SRT-LTS 
Mean (±SD) 54.1 (±10.1) 38.0 (±12.4) 57.1 (±14.4) 56.3 (±9.2) 
Norm 
(percentile) 
40th %ile 20th %ile 52th %ile 58th %ile 
Fluency score RWT score RWT score WLG score WLG score 
Mean (±SD) 22.7 (±3.4) 21.5 (±4.9) 24.8 (±7.4) 26.7 (±5.6) 
Norm 
(percentile) 
35th %ile 57th %ile 31th %ile 57th %ile 
BDI-IIc 8 (0–17) 8 (1–22) 6.5 (0–26) 11.5 (0–29) 
Median (range)  
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3. Results 
Hippocampal deformations were observed in NMDAR encephalitis, 
LGI1 encephalitis and relapsing remitting multiple sclerosis (RRMS), but 
not in NMOSD (Fig. 1; see Fig. S1 for FDR threshold information). 
Volumetric results were in line with these observations (Table 2). 
3.1. NMDAR encephalitis 
In NMDAR encephalitis, an inward deformation of the surface was 
noted on the head of the left hippocampus (Fig. 1A). Atrophic regions 
extended medially and laterally along the hippocampal axis, corre-
sponding to subfields CA1-3 and subiculum (p < .001). The same pattern 
was observed for the right hippocampus, but only two smaller clusters 
survived correction for multiple comparisons (p = .034). 
We next determined the magnitude of displacement from the mean 
surface across the whole structure (Table 3). Surface deformations were 
− 0.30 mm for the left hippocampus and − 0.16 mm for the right hip-
pocampus in the patient group. When compared to controls, this mean 
displacement of the hippocampal surface was significant for the left 
hippocampus (F(1,58) = 13.88, p < .001), but did not reach statistical 
significance for the right hippocampus (F(1,58) = 3.71, p = .059; 
Fig. 1A). 
Correlational analyses revealed an association of the surface de-
formations with verbal learning performance: the stronger the inward 
movement of the surface cluster in the patient group, the fewer words 
were learned during word list learning (RAVLT sum score; r = .335, p =
.035, n = 30). We observed no association with word fluency (r = − .033, 
Fig. 1. Hippocampal shape deformations. Upper panels: Colored regions show significant inward deformation of the hippocampal surface (p < .05; multiple- 
comparison corrected). Top row: Surface deformations of the left hippocampus are shown in a dorsolateral perspective. Bottom row: Deformations of the left and 
right hippocampus are shown in ventral and dorsal view. Lower panel: Scalar projection values of the hippocampus show the average displacement of the hippo-
campal surface with respect to the control groups (in mm; *p < .05; **p < .01). (For interpretation of the references to colour in this figure legend, the reader is 
referred to the web version of this article.) 
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p = .432, n = 30), depression screening scores (rs = − .100, p = .356, n =
16), treatment delay (r = .150, p = .237, n = 25), time since onset (r =
.021, p = .455, n = 30), or functional outcome (mRS; rs = − .120, p =
.265, n = 30). In addition, both hippocampi showed a significantly 
reduced volume (left: − 13.3%, F(1,58) = 20.98, p < .001; right: − 8.1%, 
F(1,58) = 6.45, p = .014; Table 2). 
ROC analyses revealed that surface deformations of the left hippo-
campus significantly differentiated between patients and controls (area 
under the curve (AUC) ± standard error = 0.751 ± 0.065, p = .001; 
Fig. 2A; Table 4). This fair to good diagnostic performance was com-
parable to that of volume measurements (AUC = 0.803 ± 0.058, p <
.001). ROC performance for the right hippocampus was poor for both 
scalar displacement values (AUC = 0.636 ± 0.073, p = .070) and vol-
umes (AUC = 0.678 ± 0.070, p = .018). Interestingly, the combination 
of shape and volume measures improved the classification performance 
for both the left (AUC = 0.823 ± 0.053, p < .001, excellent) and right 
hippocampus (AUC = 0.712 ± 0.067, p < .005, fair to good) as 
compared to any of the measures alone. 
3.2. LGI1 encephalitis 
LGI1 encephalitis was characterized by a significant bilateral inward 
movement of the hippocampal surface. Affected regions encompassed 
the anterior hippocampus bilaterally in the area of CA1-3 (left, p = .005; 
right, p = .004). Atrophy was more extensive on the right hippocampus, 
where it extended laterally into area CA1 towards the tail and covered 
almost the whole ventral posterior surface, corresponding to the sub-
fields CA1 and subiculum (Fig. 1B). 
We observed a significant surface displacement of − 0.36 mm for the 
left (F(1,58) = 8.13, p = .006) and − 0.34 mm for the right hippocampus 
(F(1,58) = 9.63, p = .003; Fig. 1B). Inward movement of the surface 
cluster correlated with decreased word fluency (r = .444, p = .017, n =
23), but not with depression screening scores (rs = − .371, p = .117, n =
12), functional outcomes (mRS; rs = − .146, p = .221, n = 30), or 
duration since onset (r = .210, p = .142, n = 28). A longer treatment 
delay was, however, associated with a stronger inward deformation (r =
− .422, p = .020, n = 24). 
While overall left hippocampal surface displacement correlated with 
worse verbal memory outcome (r = .348, p = .041, n = 26), no such 
correlation was observed in controls (RAVLT sum score; r = .032, p =
.874, n = 30), suggesting that the association between surface 
displacement and cognition is a feature of disease pathology and not a 
physiological association. Volumetry revealed bilateral atrophy (left: 
− 12.7%, F(1,58) = 9.86, p = .003; right: − 15.5%, F(1,58) = 17.94, p <
.001). 
Surface deformations significantly differentiated between patients 
with LGI1 encephalitis and controls in the ROC analyses (left: AUC =
0.721 ± 0.066, p = .003; right: AUC = 0.738 ± 0.066, p = .002; Fig. 2B; 
Table 4). Diagnostic performance was of comparable precision in the 
volumetric approach (left: AUC = 0.723 ± 0.066, p = .003; right: AUC =
0.781 ± 0.059, p < .001), and improved when both measures were 
combined (left: AUC = 0.731 ± 0.065, p = .002; right: AUC = 0.786 ±
0.059, p < .001). 
3.3. Relapsing-remitting multiple sclerosis (RRMS) 
In RRMS, a significant bilateral inward deformation of the hippo-
campal surface was observed (Fig. 1C). Atrophic regions covered the 
anterior hippocampi in areas corresponding to the subfields CA1-3 and 
were more pronounced on the left side (left, p = .001; right, p = .002). 
Further significant clusters were noted towards the tail of the left hip-
pocampus. On the right hippocampus, inward deformations also 
encompassed the whole medial surface and extended towards the tail in 
the subicular area. 
We noted surface deformations of − 0.22 mm for the left hippo-
campus (F(1,58) = 8.35, p = .005) and − 0.24 mm for the right hippo-
campus (F(1,58) = 6.34, p = .015; Fig. 1C). Patients with a stronger 
inward movement of the affected surface area generated fewer words on 
the word list generation test (r = .540, p = .010, n = 18). Additionally, a 
stronger inward deformation was associated with a longer disease 
duration (r = − .583, p < .001, n = 30) and higher load of T2- 
hyperintense lesions (r = − 0.457, p = .006, n = 30). We observed no 
association with verbal learning (r = .035, p = .445, n = 18), depression 
screening scores (rs = 0.238, p = .103, n = 30), or functional outcomes 
Table 2 
Hippocampal volumes. Volumes were estimated using automated segmentation 







F p-value Partial 
η2 



















0.014*  0.100 







































0.001**  0.166 

















(0.771)  0.001 
(*p < .05, **p < .01) 
Table 3 
Scalar projection values of the hippocampus. Total displacement values show the magnitude of the disease-related inversion of the hippocampal surface (averaged 
across the whole structure). Scalar values for the individual patient and control groups represent the distance to the mean surface in the analysis that is created from 
both groups.    
Total displace-ment Patients (mean ± SEM) Controls (mean ± SEM) F p-value Partial η2 
NMDA Left − 0.30 mm − 0.15 (±0.07) mm 0.15 (±0.04) mm F(1,58) = 13.9 < 0.001**  0.193 
Right − 0.16 mm − 0.08 (±0.06) mm 0.08 (±0.06) mm F(1,58) = 3.7 0.059  0.060 
LGI1 Left − 0.36 mm − 0.18 (±0.11) mm 0.18 (±0.06) mm F(1,58) = 8.1 0.006**  0.123 
Right − 0.34 mm − 0.17 (±0.09) mm 0.17 (±0.06) mm F(1,58) = 9.6 0.003**  0.142 
RRMS Left − 0.22 mm − 0.11 (±0.05) mm 0.11 (±0.06) mm F(1,58) = 8.4 0.005**  0.126 
Right − 0.24 mm − 0.12 (±0.07) mm 0.12 (±0.06) mm F(1,58) = 6.3 0.015*  0.098 
NMOSD Left 0.06 mm 0.03 (±0.04) mm − 0.03 (±0.06) mm F(1,58) = 0.6 (0.456)  0.010 
Right 0.04 mm 0.02 (±0.05) mm − 0.02 (±0.06) mm F(1,58) = 0.3 (0.613)  0.004 
(*p < .05, **p < .01) 
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(EDSS; rs = .165, p = .192, n = 30). 
Both hippocampi showed a significantly decreased volume (left: 
− 12.1%, F(1,58) = 19.9, p < .001; right: − 11.3%, F(1,58) = 11.5, p =
.001). Deformations of the hippocampal surface significantly differen-
tiated between patients with RRMS and controls (Fig. 2C; Table 4). This 
diagnostic performance was better for the left (AUC = 0.723 ± 0.067, p 
= .003) than for the right hippocampus (AUC = 0.678 ± 0.071, p =
.018) and slightly inferior to that of the volumetric estimates (left: AUC 
= 0.802 ± 0.057, p < .001; right: AUC = 0.724 ± 0.068, p = .003). The 
combination of shape and volume information achieved the best clas-
sification performance (left: AUC = 0.853 ± 0.048, p < .001, excellent; 
right: AUC = 0.781 ± 0.061, p < .001, fair to good). 
3.4. Neuromyelitis optica spectrum disorders (NMOSD) 
No shape differences were observed for the left (p = .26) and right (p 
Fig. 2. Receiver operating characteristics (ROC) for hippocampal scalar values, hippocampal volumes, and their combined classification performance. 1-specificity 
and sensitivity of the derived displacement measure are plotted on the x and y axes. The average scalar values of the left and right hippocampi (solid lines) show 
comparable diagnostic performance to that of conventional volumetric measures (dotted lines). Combining shape and volume information yielded the best classi-
fication performance across all diseases. 
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= .53) hippocampus in NMOSD patients (Fig. 1D). Mean displacement 
was − 0.06 mm for the left and − 0.04 mm for the right hippocampus, 
with no significant group difference (left: F(1,58) = 0.56, p = .46; right: F 
(1,58) = 0.26, p = .61; Fig. 1D). 
Volumetric analyses showed no hippocampal atrophy (left, F(1,58) 
= 0.11, p = .740; right, F(1,58) = 0.09, p = .771). Accordingly, the ROC 
classifier performed at chance level when testing surface deformations 
(left: AUC = 0.452 ± 0.076, p = .520; right: AUC = 0.479 ± 0.075, p =
.779), volumes (left: AUC = 0.474 ± 0.076, p = .734; right: AUC = 0.502 
± 0.076, p = .976; Fig. 2D; Table 4), and the combination of shape and 
volume information (left: AUC = 0.589 ± 0.074, p = .237; right: AUC =
0.533 ± 0.076, p = .657). 
3.5. Overlap of surface deformations 
In the next step, we quantified the surface deformation overlaps 
across the NMDAR encephalitis, LGI1 encephalitis and RRMS patient 
groups (Fig. 3). Binarized coding of the surface area revealed significant 
overlaps in each of the pair-wise comparisons with varying contin-
gencies (2-sided, exact significance). 
3.5.1. NMDAR encephalitis vs. RRMS 
Surface deformations on the left hippocampus affected 32.0% of the 
vertices in NMDAR encephalitis and 20.8% in the multiple sclerosis 
group. Lesion patterns in both disorders correlated strongly (Φ = 0.440, 
p < .0001): 72% of the surface vertices that were affected in multiple 
sclerosis were also affected in NMDAR encephalitis. Vice versa, 47% of 
the vertices showing inversion in NMDAR encephalitis overlapped with 
multiple sclerosis. 
On the right hippocampus, 26.5% of the surface vertices were signif-
icantly inverted in multiple sclerosis. Only 0.02% of the vertices were 
affected in NMDAR encephalitis when thresholded to a significance level 
of p < .05. Accordingly, the overlap was significant but with low con-
tingency for the right side (Φ = 0.205, p < .0001; Fig. 3A) and only 7% 
of the vertices affected in multiple sclerosis were also deformed in 
NMDAR encephalitis. 
3.5.2. LGI1 encephalitis vs. RRMS 
Left-sided deformations covered 27.6% of the surface vertices in LGI1 
encephalitis. We observed a significant overlap with moderate contin-
gency (Φ = 0.386, p < .0001): Out of the vertices affected in LGI1 en-
cephalitis, 46% overlapped with multiple sclerosis. Vice versa, 62% of 
the inverted surface vertices in multiple sclerosis were also affected in 
LGI1 encephalitis (Fig. 4). On the right hippocampus, LGI1 encephalitis 
affected 38.2% of the surface vertices. As observed in the previous 
comparison, the right-sided overlap was significant, with an albeit lower 
correlation (Φ = 0.260, p < .0001; Fig. 3B). Furthermore, 41% of the 
Table 4 
Receiver operating characteristics (ROC).    
Volume Scalar Volume + Scalar 
NMDA Left 0.678 (±0.070), p 
< .001 
0.751 (±0.065), p 
= .001 
0.823 (±0.053), p 
< .001  
Right 0.636 (±0.073), p 
= .018 
0.678 (±0.070), p 
= .070 
0.712 (±0.067), p 
< .005 
LGI1 Left 0.723 (±0.066), p 
= .003 
0.721 (±0.066), p 
= .003 
0.731 (±0.065), p 
= .002  
Right 0.781 (±0.059), p 
< .001 
0.738 (±0.066), p 
= .002 
0.786 (±0.059), p 
< .001 
RRMS Left 0.802 (±0.057), p 
< .001 
0.723 (±0.067), p 
= .003 
0.853 (±0.048), p 
< .001  
Right 0.724 (±0.068), p 
= .003 
0.678 (±0.071), p 
= .018 
0.781 (±0.061), p 
< .001 
NMOSD Left 0.474 (±0.076), p 
= .734 
0.452 (±0.076), p 
= .520 
0.589 (±0.074), p 
= .237  
Right 0.502 (±0.076), p 
= .976 
0.479 (±0.075), p 
= .779 
0.533 (±0.076), p 
= .657  
Fig. 3. Pairwise overlaps of surface deformations in ventral (upper panel) and dorsal view (lower panel). (A) Multiple sclerosis (yellow) and NMDAR encephalitis 
(blue) overlapped strongly on the left hippocampus (Φ = 0.440; contingency coefficient). More than 70% of the affected vertices in multiple sclerosis were also 
affected in NMDAR encephalitis. (B) LGI1 encephalitis (red) and multiple sclerosis (yellow) overlapped with moderate contingency on the left (Φ = 0.386) and right 
(Φ = 0.260) hippocampus. Surface deformations overlap around 50% on both sides. (C) Overlap of NMDAR (blue) and LGI1 encephalitis (red) was stronger for the 
left (Φ = 0.268) than for the right hippocampus (Φ = 0.108). Around 50% of the surface inversions overlapped. (For interpretation of the references to colour in this 
figure legend, the reader is referred to the web version of this article.) 
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inverted vertices in LGI1 encephalitis were also inverted in multiple 
sclerosis; and 59% vice versa. 
3.5.3. NMDAR encephalitis vs. LGI1 encephalitis 
In NMDAR and LGI1 encephalitis, affected areas overlapped signif-
icantly, but contingency was weaker than for the previous comparisons 
(left: Φ = 0.268, p < .0001; right: Φ = 0.108, p < .0001; Fig. 3C). For the 
left hippocampus, 45% of the inverted vertices in NMDAR encephalitis 
overlapped with LGI1 encephalitis; and 52% vice versa. Overlaps on the 
right hippocampus were negligible due to the small affected area in 
NMDAR encephalitis. 
3.5.4. Common deformation zone in NMDAR encephalitis, LGI1 
encephalitis and RRMS 
Regions that were affected across NMDAR encephalitis, LGI1 en-
cephalitis and RRMS overlapped in a convergence zone on the left ante-
rior hippocampus corresponding to the surface area of CA1 (Fig. 4). 
Deformations in this overlap area correlated with cognitive performance, 
i.e. with verbal memory in NMDAR encephalitis (r = .342, p = .032, n =
30) and verbal fluency in LGI1 encephalitis (r = .395, p = .031, n = 23). 
4. Discussion 
In this study, we performed transdiagnostic hippocampal shape an-
alyses in four neuroimmunological diseases using a unified imaging 
protocol. Our analysis revealed a characteristic pattern of bilateral in-
ward deformations of the hippocampal surface in multiple sclerosis, 
NMDAR encephalitis and LGI1 encephalitis, but not in NMOSD. Surface 
deformations discriminated significantly between patients of these three 
disorders and controls. Higher inward deformation of the hippocampal 
surface predicted decreased semantic fluency in multiple sclerosis and 
impaired verbal memory performance in both NMDAR and LGI1 en-
cephalitis. Analysis of deformation overlaps revealed a convergence 
zone in the left anterior hippocampus that corresponds to the CA1 
subfield of the hippocampus and that appears to be particularly 
vulnerable to neuroinflammatory processes. 
In NMDAR encephalitis, the most frequent subtype of autoimmune 
encephalitis (Dalmau and Graus, 2018), deformations were mainly 
observed in surface areas that correspond to the CA1-3 subfields and 
subiculum. Given that an inversion of the surface likely reflects volume 
loss of underlying tissue, it is not surprising that the location of shape 
deformations resembles those subfields that also showed volume loss in 
volumetric analyses (Finke et al., 2016a; Heine et al., 2015). Indeed, 
NMDAR patients had lower volumes of the subiculum as well as CA1 and 
CA2-3 areas. This is in line with the finding that the hippocampus, 
specifically CA1, contains the highest density of NMDARs in the brain 
(Monaghan and Cotman, 1985). Furthermore, recent studies observed 
functional decoupling of the hippocampus from major brain networks 
such as the default mode network, which was related to impaired 
memory performance in NMDAR encephalitis patients (Peer et al., 2017; 
Finke et al., 2013). The pathogenic effects of antibodies in NMDAR 
encephalitis are thus not only reflected in focal hippocampal damage, 
but also result in functional network alterations. 
LGI1 encephalitis showed the most extensive shape deformations in 
this comparative study, covering up to 32% of the hippocampal surface 
area. Previous studies have shown that almost all LGI1 encephalitis 
Fig. 4. Overlap analyses reveal an area of the left anterior hippocampus that is affected across diseases and sensitive to cognitive alterations.  
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patients develop hippocampal atrophy that arises from volume loss in 
several subfields, including the CA1, CA2-3 areas, the dentate gyrus and 
subiculum (Finke et al., 2017; Miller et al., 2017). The absence of further 
cortical grey matter loss suggests that long-term structural damage is 
localized to the hippocampus (Finke et al., 2017; Miller et al., 2017), 
while functional connectivity alterations can involve brain-wide net-
works (Heine et al., 2018). Shape deformations in our study were 
located in the surface areas approximately corresponding to the cornu 
ammonis and subicular subfields. The inward movement of the bilateral 
surfaces correlated with impaired verbal learning and fluency, sug-
gesting that shape alterations may represent a complementary expla-
nation of cognitive deficits in LGI1 encephalitis. 
For MS patients, our analyses show a bilateral inward deformation of 
the hippocampal surface associated with decreased word fluency. 
Beyond conventional MRI measures such as white matter lesion count or 
volume that do not sufficiently explain cognitive deficits, there is 
increasing evidence for hippocampal damage in MS (Filippi et al., 2010; 
Sumowski et al., 2018). Indeed, hippocampal demyelination and 
neuronal loss are common and can affect all hippocampal subfields 
(Rocca et al., 2018; Papadopoulos et al., 2009). MRI studies observed 
bilateral volume loss as well as impaired microstructural integrity of the 
hippocampus (Sicotte et al., 2008; Anderson et al., 2010; Gold et al., 
2010; Planche, 2017). Additionally, recent studies showed alterations of 
structural and functional connectivity of the hippocampus, as well as 
aberrant activation during memory encoding (Rocca et al., 2018; Di 
Filippo et al., 2018; Hulst et al., 2012). Local pathology due to inflam-
matory and degenerative changes may thus interact with damage to 
connected white matter tracts and cortical regions (Rocca et al., 2018; Di 
Filippo et al., 2018) – eventually inducing widespread deficits that also 
affect processing speed and executive function (Paul, 2016). Hippo-
campal shape changes occurred bilaterally in our study and were pro-
nounced on the left side. This cluster on the left anterior hippocampus 
approximately identifies as CA1 subfield but also extends to the areas of 
the subfields CA2-3. Importantly, previous volumetric subregion ana-
lyses revealed a similar pattern: Progressive CA1 atrophy was related to 
slowed processing speed, verbal and visuospatial memory deficits 
(Sicotte et al., 2008; Gold et al., 2010; Longoni et al., 2015). This atro-
phy expanded to other subfields with progression to secondary pro-
gressive multiple sclerosis (Sicotte et al., 2008). In addition, smaller 
CA2-3 volumes were observed in multiple sclerosis patients with 
depression (Gold et al., 2010). Together, these results point to a critical 
involvement of distinct hippocampal subregions in the pathophysiology 
of cognitive and affective symptoms in MS. 
In contrast, we observed no shape deformations of the hippocampus 
in NMOSD patients. This result is in line with previous observations of 
normal hippocampal volumes and intact microstructural integrity in 
NMOSD (Finke et al., 2016b; Hyun et al., 2017). Other studies, however, 
found decreased hippocampal volumes in a cognitively impaired sample 
of Chinese patients (Liu et al., 2015), as well as in NMOSD patients with 
depression and anxiety symptoms (Chen et al., 2019). Whether this 
observation is limited to NMOSD patients with pronounced cognitive 
impairment or affective symptoms, or reflects differences in disease 
phenotypes related to ethnicity, remains an open question. Similarly, 
evidence for the contribution of damage to further subcortical and 
cortical regions to cognitive deficits in NMOSD remains inconsistent. 
While some studies found no cortical lesions (Calabrese et al., 2012), no 
cortical demyelination (Popescu et al., 2010) or subcortical volume loss 
(Finke et al., 2016b), others observed decreased thalamic volumes 
(Wang et al., 2015). In our study, we focused on AQP4 antibody-positive 
NMOSD patients and the apparent sparing of the hippocampus may be 
related to the distribution of AQP4 in periventricular and hypothalamic 
areas (Pittock et al., 2006). It thus remains an important open question 
whether hippocampal damage patterns are different in AQP4-negative 
NMOSD patients, and how they differ from NMOSD patients with anti-
bodies against the myelin oligodendrocyte glycoprotein (MOG). 
Shape deformations shared by NMDAR encephalitis, LGI1 
encephalitis and multiple sclerosis converged on the anterolateral sur-
face of the hippocampus, a surface area mainly covering the CA1 sub-
field. CA1 relays input from the CA3-DG circuitry and entorhinal cortex 
downstream to the subicular output areas and back to the entorhinal 
cortex, i.e. the hippocampal-neocortical interfaces. CA1 neurons are 
critically involved in memory formation and consolidation and 
dysfunction of these neurons leads to severe memory impairment, 
including input integration, mismatch and novelty detection, as well as 
intermediate and long-term autobiographical memory retrieval (Bartsch 
and Wulff, 2015; Kesner and Hunsaker, 2010). A selective vulnerability 
of the CA1 subfield has not only been described in limbic encephalitis 
(Bartsch et al., 2015) and MS (Sicotte et al., 2008), but also in other 
neurological disorders such as transient global amnesia, epilepsy and 
ischemia (Bartsch et al., 2015; Gee et al., 2006). Conceivable mecha-
nisms for CA1 vulnerability include its high inherent degree of plasticity, 
local differences in antioxidant enzymes as well as calcium- and 
glutamate-related excitotoxicity of CA1 neurons affecting the metabolic 
homeostasis (Bartsch and Wulff, 2015). Interestingly, the trans-
diagnostic pattern of anterolateral hippocampal deformations observed 
in our study is also a prominent finding in Alzheimer’s disease (Gerardin 
et al., 2009; Li et al., 2007). Mainly left-sided CA1 shape changes 
furthermore predicted dementia onset in healthy elderly subjects and 
patients with mild cognitive impairment (MCI) (Csernansky et al., 2005; 
Achterberg et al., 2014). In face of the overlapping nature of cognitive 
symptoms across neurological diseases, it has been suggested that the 
same ensemble of disrupted brain regions causes a clinical phenotype to 
arise regardless of conventional diagnostic demarcations (Husain, 
2017). In line with this transdiagnostic approach, our data support the 
notion that damage to CA1 and its surface area is one of the main con-
tributors to deficits of memory formation and consolidation in neuro-
immunological disorders, as well as in a wide range of other 
neuropsychiatric diseases. 
Shape changes in our samples additionally extended to surface areas 
that can be approximately identified as belonging to hippocampal sub-
fields CA2 and CA3. The CA3 subregion is involved in associative memory 
and pattern completion (Gold and Kesner, 2005), a computational process 
in which entire memory representations can be recalled in response to the 
presentation of one of its parts. Together with the dentate gyrus, CA3 also 
plays a role in creating non-overlapping memory representations, a pro-
cess referred to as pattern separation (Bakker et al., 2008). CA3 volume 
loss is observed both in autoimmune encephalitides (Finke et al., 2017, 
2016a; Miller et al., 2017) and MS, particularly when depressive symp-
toms are present (Gold et al., 2010). Besides the autoimmune pathology, 
glucocorticoid receptor activation in response to disease-related behav-
ioural stress may additionally contribute to CA2-3 (Sapolsky et al., 1990) 
and CA1 (Bartsch and Wulff, 2015) vulnerability. 
In contrast to volumetric approaches, surface analyses provide 
detailed information about the location of pathological changes of the 
hippocampus. These analyses have been shown to discriminate between 
patients with neuropsychiatric disorders and controls and to reliably track 
disease progression. For example, morphological changes of the hippo-
campal surface successfully differentiated patients with MCI and patients 
with Alzheimer’s disease (AD) from healthy controls (Gerardin et al., 
2009; Li et al., 2007), with superior performance compared to volumetric 
measures (Gerardin et al., 2009). In schizophrenia, left–right asymmetry 
of hippocampal shape was observed in patients even in the absence of 
volume loss (Csernansky et al., 2002; Shenton et al., 2002). In line with 
this, we show that the combination of shape and volume information 
yields a better classification performance than any of the measure alone. 
Together with previous findings in neuropsychiatric diseases, our results 
suggest that shape may be a sensitive marker of – even early – damage. 
Although shape analyses have made substantial contributions, some 
limitations need to be considered. The nature of shape analyses limits 
the findings of this study to the outer surface of the hippocampus. 
Considering the intricate hippocampal anatomy, this technique allows 
no assumptions about inner structures, e.g. the dentate gyrus. However, 
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results from our and previous studies suggest that a combination of 
different approaches including shape, volumetric and microstructural 
integrity analyses provides more detailed pathophysiological insights 
and yields an improved discriminatory power. In addition, despite 
assessing the same underlying construct and using an equivalent 
multiple-trial list-learning approach, minor differences in test versions 
used for verbal memory need to be taken into account. Future longitu-
dinal studies may explore whether the deformations are transient or 
chronic, and to which extend they might serve as predictors for long- 
term functional outcomes. 
5. Conclusion 
In conclusion, we show that hippocampal shape deformations are 
common and highly overlapping across neuroimmunological diseases and 
contribute to cognitive symptoms. Our comparative approach reveals a 
convergence zone on the left anterolateral surface, mainly corresponding 
to subfield CA1 that appears to be most vulnerable to neuroinflammation 
- despite the distinct pathomechanisms in multiple sclerosis and autoim-
mune encephalitides. In this way, it improves the understanding of 
cognition networks in health and disease and stimulates further basic 
research into the mechanisms of increased susceptibility to autoimmunity 
of this anatomical region. This morphological view provides unique 
spatial information about the pattern of hippocampal lesions, tran-
scending traditional global measures of hippocampal volume. 
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